|
Name |
4′-Hydroxycytochalasin J3
|
Molecular Formula | C28H35NO4 | |
IUPAC Name* |
2-hydroxy-15-[(4-hydroxyphenyl)methyl]-5,7,13-trimethyl-12-methylidene-18-oxa-16-azapentacyclo[8.7.1.11,4.014,18.09,19]nonadec-5-en-17-one
|
|
SMILES |
C=C1C(C)C2C(Cc3ccc(O)cc3)NC(=O)C23C(O)CC2C(C)=CC(C)CC4OC1C3C42
|
|
InChI |
InChI=1S/C28H35NO4/c1-13-9-14(2)19-12-22(31)28-24(15(3)16(4)26-25(28)23(19)21(10-13)33-26)20(29-27(28)32)11-17-5-7-18(30)8-6-17/h5-9,13,15,19-26,30-31H,4,10-12H2,1-3H3,(H,29,32)/t13-,15-,19+,20+,21-,22-,23-,24+,25+,26-,28-/m1/s1
|
|
InChIKey |
PUYHZTVFLBKAGB-HCCCHLSPSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 449.59 | ALogp: | 3.6 |
HBD: | 3 | HBA: | 4 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 78.8 | Aromatic Rings: | 6 |
Heavy Atoms: | 33 | QED Weighted: | 0.588 |
Caco-2 Permeability: | -4.897 | MDCK Permeability: | 0.00003310 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.026 |
Human Intestinal Absorption (HIA): | 0.049 | 20% Bioavailability (F20%): | 0.035 |
30% Bioavailability (F30%): | 0.028 |
Blood-Brain-Barrier Penetration (BBB): | 0.09 | Plasma Protein Binding (PPB): | 94.70% |
Volume Distribution (VD): | 1.733 | Fu: | 6.28% |
CYP1A2-inhibitor: | 0.028 | CYP1A2-substrate: | 0.508 |
CYP2C19-inhibitor: | 0.48 | CYP2C19-substrate: | 0.749 |
CYP2C9-inhibitor: | 0.191 | CYP2C9-substrate: | 0.352 |
CYP2D6-inhibitor: | 0.045 | CYP2D6-substrate: | 0.852 |
CYP3A4-inhibitor: | 0.88 | CYP3A4-substrate: | 0.657 |
Clearance (CL): | 14.577 | Half-life (T1/2): | 0.024 |
hERG Blockers: | 0.108 | Human Hepatotoxicity (H-HT): | 0.633 |
Drug-inuced Liver Injury (DILI): | 0.043 | AMES Toxicity: | 0.035 |
Rat Oral Acute Toxicity: | 0.905 | Maximum Recommended Daily Dose: | 0.898 |
Skin Sensitization: | 0.03 | Carcinogencity: | 0.042 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.007 |
Respiratory Toxicity: | 0.955 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003956 | 0.802 | D0S2BV | 0.264 | ||||
ENC006060 | 0.652 | D06XZW | 0.228 | ||||
ENC003936 | 0.643 | D0B3QM | 0.217 | ||||
ENC005127 | 0.611 | D06ALD | 0.216 | ||||
ENC004119 | 0.525 | D01TNW | 0.214 | ||||
ENC005128 | 0.508 | D04UTT | 0.214 | ||||
ENC003937 | 0.476 | D0H0SJ | 0.214 | ||||
ENC004371 | 0.472 | D06WTZ | 0.211 | ||||
ENC005759 | 0.447 | D0VA0I | 0.211 | ||||
ENC004372 | 0.444 | D01CRB | 0.210 |